CN105536029B - A kind of preparation method of chitosan multi-porous styptic sponge - Google Patents

A kind of preparation method of chitosan multi-porous styptic sponge Download PDF

Info

Publication number
CN105536029B
CN105536029B CN201510990788.XA CN201510990788A CN105536029B CN 105536029 B CN105536029 B CN 105536029B CN 201510990788 A CN201510990788 A CN 201510990788A CN 105536029 B CN105536029 B CN 105536029B
Authority
CN
China
Prior art keywords
solution
chitosan
added
preparation
porous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510990788.XA
Other languages
Chinese (zh)
Other versions
CN105536029A (en
Inventor
蓝广芊
卢必涛
代方银
陈景浩
余堃
刘佳伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou and its beauty biological materials Co., Ltd.
Original Assignee
蓝广芊
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 蓝广芊 filed Critical 蓝广芊
Priority to CN201510990788.XA priority Critical patent/CN105536029B/en
Publication of CN105536029A publication Critical patent/CN105536029A/en
Application granted granted Critical
Publication of CN105536029B publication Critical patent/CN105536029B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/425Porous materials, e.g. foams or sponges

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

The invention discloses a kind of preparation methods of chitosan multi-porous styptic sponge, include the following steps:Step 1, the preparation of solution;Step 2, the preparation of chitosan multi-porous styptic sponge, chitosan solution, gelatin solution and glycerite is taken to be thoroughly mixed in 25 DEG C of water bath conditions according to 3: 3: 1 volume ratio, obtain mixing milk white gel liquid, then calcium chloride solution is taken to be added, it is sufficiently stirred 30min in 25 DEG C of water bath conditions, tannic acid solution is taken to be added again, continue to stir 20min in 25 DEG C of water bath conditions, it obtains mixing red red gel liquid, calcium chloride solution and tannic acid solution distinguish accounting 0.5% and 0.01% in obtained mixing pellet red gel liquid;The red red gel liquid of mixing is taken, is poured into mold, pre-freeze 12h or more is in obtain chitosan multi-porous styptic sponge after ice cube shape, then vacuum freeze drying 48h.Advantageous effect is:Prepare simple, finished product chitosan content is high, can natural degradation, the fast, good anti-bacterial effect of anthemorrhagic speed etc..

Description

A kind of preparation method of chitosan multi-porous styptic sponge
Technical field
The invention belongs to hemostatic material in medical use preparation field, the preparation side of specifically a kind of chitosan multi-porous styptic sponge Method.
Background technology
For many years, more and more about the research of hemostatic material, mostly it is the hemostatic material that natural products can degrade in vivo Material, such as Fibrin Glue, powdered collagen, gelfoam, but these materials all have some disadvantages, fiber egg White glue is only limited to topical application, may infect the blood borne disease of human or animal in the blood plasma of people or mammal;Glue Former albumen may lead to wound fever and allergy as a kind of foreign matter;Gelfoam bad mechanical property, is easily broken.Also one The hemostatic material of a little foreign countries' imports, such as speed is yarn, expensive although haemostatic effect is good, is limited its scope of application.Cause This, it is a kind of with good haemostatic effect, stronger antibiotic property, preferable wound healing promoting ability and can with degradation in vivo only Blood material is particularly significant.
Currently, there is extensive research and application prospect as hemostatic material using chitosan as main component, have only The different physiological roles such as blood, antibacterial, anticancer, lipid-loweringing, strengthen immunity and good histocompatbility and higher bioactivity, And it is nontoxic, it is non-stimulated, it can be with natural degradation.Many researchers select chitosan to prepare porous hemostasis material, generally utilize relatively low The acetum of concentration dissolves chitosan, is obtained by the method for freeze-drying.But the solubility of chitosan is relatively low, only 3%~4%.On the one hand the hemostatic material of relatively low chitosan concentration influences the haemostatic effect of hemostatic material, on the other hand influence to stop The mechanical performance of blood material.In addition to this, acetic acid has human body larger irritation, and materials'use is increased as lytic agent Insecurity.In order to improve the mechanical performance and bio-safety performance of material, it is necessary to select suitable natural biologic material It is blended and is selected nontoxic crosslinking agent to be crosslinked, while needing to reduce or eliminate the containing in material of acetic acid Amount.
As effective porous hemostasis material, suitable material or inadequate is selected, it is also necessary to by material preparation at tool There is specified pore structure, there is stronger absorbent function.The method of general drilling has particle leaching, phase separation method, freeze-drying Method, gas foaming method, sintering microballoon method etc., but suitable method for drilling how is selected, preparing has uniform pore size size, high The pore structure of porosity, and the material with good hydrophily and some strength, are still a technical barrier.
Invention content
It is prepared simply technical problem to be solved by the invention is to provide a kind of, finished product chitosan content is high, can drop naturally Solution, anthemorrhagic speed are fast, good anti-bacterial effect, nontoxic, non-stimulated, mechanical performance and bio-safety performance are good, pore size is uniform, high The preparation method of the chitosan multi-porous styptic sponge of porosity.
The technical solution that the present invention solves above-mentioned technical problem is as follows:A kind of preparation side of chitosan multi-porous styptic sponge Method includes the following steps:
Step 1, the preparation of solution:
1) chitosan solution is prepared, ascorbic acid is weighed and is added in distilled water, filled under 40 DEG C~50 DEG C water bath conditions Divide stirring and dissolving, the ascorbic acid solution of 0.05mol/L~0.3mol/L is made;It measures acetic acid and is added to constant volume in volumetric flask, The acetum that concentration expressed in percentage by volume is 0.1%~0.5% is made;Chitosan is weighed to be added in the ascorbic acid solution, After being sufficiently mixed, the acetum is added, is stirred evenly under 40 DEG C~50 DEG C water bath conditions, obtaining mass percentage concentration is 5%~8% chitosan solution is preserved and is used, wherein the acetum being added accounts for the 0.2%~0.5% of total solution;
2) gelatin solution is prepared, gelatin is weighed and is added in distilled water, fully dissolved in 40 DEG C~85 DEG C water bath conditions, The gelatin solution that mass percentage concentration is 0.5%~4% is made, preserves and uses;
3) glycerite is prepared, glycerine is weighed and is added in distilled water, stir evenly, it is 40% that mass percentage concentration, which is made, ~50% glycerite is preserved and is used;
4) prepare calcium chloride solution, weigh calcium chloride and be added in distilled water, be made mass percentage concentration be 10%~ 30% calcium chloride solution is preserved and is used;
5) crosslinking agent is prepared, tannic acid is weighed and is added in distilled water, it is 0.5%~5% that mass percentage concentration, which is made, Tannic acid solution is preserved and is used;
Step 2, the preparation of chitosan multi-porous styptic sponge:
Take the chitosan solution, gelatin solution and glycerite according to 3: 3: 1 volume ratio in 25 DEG C~50 DEG C water-baths It is thoroughly mixed in condition, obtains mixing milk white gel liquid, then take the calcium chloride solution to be added, at 25 DEG C~50 DEG C It is sufficiently stirred 30min~120min in water bath condition, then the tannic acid solution is taken to be added, in 25 DEG C~50 DEG C water bath conditions Continue to stir 20min~50min, obtains mixing red red gel liquid, described in the obtained mixing pellet red gel liquid Calcium chloride solution and tannic acid solution distinguish accounting 0.5%~4% and 0.01%~0.1%;Take the red red gel of the mixing Liquid pours into mold, pre-freeze 12h or more be in ice cube shape, then vacuum freeze drying 48h~72h after obtain chitosan multi-porous hemostasis Sponge.
The beneficial effects of the invention are as follows:Prepare simple, finished product chitosan content is high, can natural degradation, anthemorrhagic speed it is fast, anti- Bacterium effect is good, nontoxic, non-stimulated, mechanical performance and have a safety feature, pore size uniformly (aperture is 100 μm~200 μm), high Porosity.
Preferably, volumetric flask described in step 1 is the volumetric flask of 100ml, convenient for a small amount of acetum constant volume.
Preferably, the preservation of chitosan solution, glycerite, calcium chloride solution and tannic acid solution described in step 1 uses Temperature environment is 30 DEG C~40 DEG C, it is ensured that the chitosan solution, glycerite, calcium chloride solution, tannic acid solution point Minor structure stability is conducive to the preparation of chitosan multi-porous styptic sponge.
Preferably, the preservation temperature in use environment of step 1 institute gelatine solution is 30 DEG C~50 DEG C, it is ensured that the gelatin The molecular structure stabilized of solution is conducive to the preparation of chitosan multi-porous styptic sponge.
Preferably, the pre-freezing temperature environment that red red gel liquid is mixed described in step 2 is -20 DEG C~-80 DEG C, it is ensured that institute It is in ice cube shape that it is frozen, which to state the red red gel liquid of mixing, conducive to chitosan multi-porous styptic sponge is obtained.
Specific implementation mode
The principles and features of the present invention are described below, and the given examples are served only to explain the present invention, is not intended to limit Determine the scope of the present invention.
A kind of embodiment 1, preparation method of chitosan multi-porous styptic sponge, includes the following steps:
Step 1, the preparation of solution:
1) chitosan solution is prepared, ascorbic acid is weighed and is added in distilled water, filled under 40 DEG C~50 DEG C water bath conditions Divide stirring and dissolving, the ascorbic acid solution of 0.05mol/L~0.3mol/L is made;Acetic acid is measured to be added in 100ml volumetric flasks The acetum that concentration expressed in percentage by volume is 0.1%~0.5% is made in constant volume;Chitosan is weighed to be added in ascorbic acid solution, After being sufficiently mixed, acetum is added, is stirred evenly under 40 DEG C~50 DEG C water bath conditions, it is 5% to obtain mass percentage concentration ~8% chitosan solution is preserved and is used, wherein the acetum being added accounts for the 0.2%~0.5% of total solution;
2) gelatin solution is prepared, gelatin is weighed and is added in distilled water, fully dissolved in 40 DEG C~85 DEG C water bath conditions, 0.5%~4% gelatin solution is made, preserves and uses at 30 DEG C~50 DEG C;
3) glycerite is prepared, glycerine is weighed and is added in distilled water, stir evenly, obtained 40%~50% glycerine is molten Liquid is preserved at 30%~40 DEG C and is used;
4) calcium chloride solution is prepared, calcium chloride is weighed and is added in distilled water, 10%~30% calcium chloride solution is made, It preserves and uses at 30%~40 DEG C;
5) crosslinking agent is prepared, tannic acid is weighed and is added in distilled water, obtained 0.5%~5% tannic acid solution, 30% It preserves and uses at~40 DEG C;
Step 2, the preparation of chitosan multi-porous styptic sponge:
Take the chitosan solution, gelatin solution and glycerite according to 3: 3: 1 volume ratio in 25 DEG C of water bath conditions It is thoroughly mixed, obtains mixing milk white gel liquid, then take the calcium chloride solution to be added, filled in 25 DEG C of water bath conditions Divide stirring 60min, then the tannic acid solution is taken to be added, continue to stir 50min in 25 DEG C of water bath conditions, it is red to obtain mixing pellet Color coagulant liquid, the calcium chloride solution described in the obtained mixing pellet red gel liquid and tannic acid solution distinguish accounting 0.5% and 0.01%;The red red gel liquid of the mixing is taken, is poured into mold, pre-freeze 12h is in ice under -20 DEG C of temperature conditions Chitosan multi-porous styptic sponge is obtained after bulk, then vacuum freeze drying 48h.
A kind of embodiment 2, preparation method of chitosan multi-porous styptic sponge, includes the following steps:
Step 1 is consistent with embodiment 1;
Step 2, the preparation of chitosan multi-porous styptic sponge:
Take the chitosan solution, gelatin solution and glycerite according to 3: 3: 1 volume ratio in 40 DEG C of water bath conditions It is thoroughly mixed, obtains mixing milk white gel liquid, then take the calcium chloride solution to be added, filled in 40 DEG C of water bath conditions Divide stirring 50min, then the tannic acid solution is taken to be added, continue to stir 40min in 40 DEG C of water bath conditions, it is red to obtain mixing pellet Color coagulant liquid, the calcium chloride solution described in the obtained mixing pellet red gel liquid and tannic acid solution distinguish accounting 2% With 0.05%;The red red gel liquid of the mixing is taken, is poured into mold, pre-freeze 12h is in ice cube shape under -50 DEG C of temperature conditions, Again chitosan multi-porous styptic sponge is obtained after vacuum freeze drying 60h.
Embodiment 3, a kind of preparation method of chitosan multi-porous styptic sponge includes the following steps:
Step 1 is consistent with embodiment 1;
Step 2, the preparation of chitosan multi-porous styptic sponge:
Take the chitosan solution, gelatin solution and glycerite according to 3: 3: 1 volume ratio in 50 DEG C of water bath conditions It is thoroughly mixed, obtains mixing milk white gel liquid, then take the calcium chloride solution to be added, filled in 50 DEG C of water bath conditions Divide stirring 30min, then the tannic acid solution is taken to be added, continue to stir 20min in 50 DEG C of water bath conditions, it is red to obtain mixing pellet Color coagulant liquid, the calcium chloride solution described in the obtained mixing pellet red gel liquid and tannic acid solution distinguish accounting 0.4% and 0.1%;The red red gel liquid of the mixing is taken, is poured into mold, pre-freeze 12h is in ice cube under -80 DEG C of temperature conditions Chitosan multi-porous styptic sponge is obtained after shape, then vacuum freeze drying 72h.
Experiment case study 1:
Arteria auricularis hemostasis experiment is carried out with porous chitosan styptic sponge made from embodiment 1:Porous chitosan is stopped blooding It is spare that sponge is cut into 30 × 30 × 5mm specifications, and New Zealand is taken to test White Rabbit, and anesthesia is fixed on operating table, and it is dynamic to shave off rabbit ear Hair on arteries and veins takes left or right ear, cuts off arteria auricularis at away from have sharp ears 7cm, wipes floating blood, gently with porous chitosan styptic sponge It pushes down, 200g weights is then taken to be pressed on styptic sponge, start timing, the gelfoam of market sale is selected in control, with market The gelfoam of sale is compared, and bleeding stopping period shortening connects by about one time.
Experiment case study 2:
With porous chitosan styptic sponge liver hemostasis experiment made from embodiment 1:Porous chitosan styptic sponge is cut It is spare at 30 × 30 × 5mm specifications, take the new blue White Rabbit of west experiment, anesthesia to be fixed on operating table, shave off the hair of rabbit abdomen, The upper hepatic portion in abdomen, cuts the wound of about 4 centimeter lengths, takes out liver, cuts 1cm depths on liver, the wound of 1cm long, It wipes liver surface and floats blood, wound is pushed down with porous chitosan styptic sponge, take 100g weights to be pressed on hemostasis sea, start to count When, the gelfoam of market sale is selected in control, and compared with the gelfoam of market sale, bleeding stopping period shortening connects by about one time.
The foregoing is merely presently preferred embodiments of the present invention, is not intended to limit the invention, it is all the present invention spirit and Within principle, any modification, equivalent replacement, improvement and so on should all be included in the protection scope of the present invention.

Claims (5)

1. a kind of preparation method of chitosan multi-porous styptic sponge, which is characterized in that include the following steps:
Step 1, the preparation of solution:
1) chitosan solution is prepared, ascorbic acid is weighed and is added in distilled water, fully stirred under 40 DEG C~50 DEG C water bath conditions Dissolving is mixed, the ascorbic acid solution of 0.05mol/L~0.3mol/L is made;It measures acetic acid and is added to constant volume in volumetric flask, be made The acetum that concentration expressed in percentage by volume is 0.1%~0.5%;It weighs chitosan to be added in the ascorbic acid solution, fully After mixing, the acetum is added, is stirred evenly under 40 DEG C~50 DEG C water bath conditions, it is 5% to obtain mass percentage concentration ~8% chitosan solution is preserved and is used, wherein the acetum being added accounts for the 0.2%~0.5% of total solution;
2) gelatin solution is prepared, gelatin is weighed and is added in distilled water, fully dissolved in 40 DEG C~85 DEG C water bath conditions, is made The gelatin solution that mass percentage concentration is 0.5%~4% is preserved at 30 DEG C~50 DEG C and is used;
3) prepare glycerite, weigh glycerine and be added in distilled water, stir evenly, be made mass percentage concentration be 40%~ 50% glycerite, lower preservation use;
4) calcium chloride solution is prepared, calcium chloride is weighed and is added in distilled water, it is 10%~30% that mass percentage concentration, which is made, Calcium chloride solution, lower preservation use;
5) crosslinking agent is prepared, tannic acid is weighed and is added in distilled water, the tannin that mass percentage concentration is 0.5%~5% is made Acid solution is preserved and is used;
Step 2, the preparation of chitosan multi-porous styptic sponge:
Take the chitosan solution, gelatin solution and glycerite according to 3: 3: 1 volume ratio in 25 DEG C~50 DEG C water bath conditions In be thoroughly mixed, obtain mixing milk white gel liquid, then take the calcium chloride solution to be added, in 25 DEG C~50 DEG C water-baths It is sufficiently stirred 30rnin~120min in condition, then the tannic acid solution is taken to be added, is relayed in 25 DEG C~50 DEG C water bath conditions Continuous stirring 20min~50min, obtains mixing red red gel liquid, the chlorine described in the obtained mixing pellet red gel liquid Change calcium solution and tannic acid solution distinguishes accounting 0.5%~4% and 0.01%~0.1%;The red red gel liquid of the mixing is taken, It pours into mold, pre-freeze 12h or more is extra large in chitosan multi-porous hemostasis is obtained after ice cube shape, then vacuum freeze drying 48h~72h It is continuous.
2. a kind of preparation method of chitosan multi-porous styptic sponge according to claim 1, which is characterized in that step 1 institute State the volumetric flask that volumetric flask is 100ml.
3. a kind of preparation method of chitosan multi-porous styptic sponge according to claim 1 or 2, which is characterized in that step One chitosan solution, glycerite, calcium chloride solution and tannic acid solution preservation temperature in use environment be 30 DEG C~ 40℃。
4. a kind of preparation method of chitosan multi-porous styptic sponge according to claim 1 or 2, which is characterized in that step The preservation temperature in use environment of one gelatine solution is 30 DEG C~50 DEG C.
5. a kind of preparation method of chitosan multi-porous styptic sponge according to claim 1 or 2, which is characterized in that step The pre-freezing temperature environment of the two red red gel liquid of mixing is -20 DEG C~-80 DEG C.
CN201510990788.XA 2015-12-25 2015-12-25 A kind of preparation method of chitosan multi-porous styptic sponge Active CN105536029B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510990788.XA CN105536029B (en) 2015-12-25 2015-12-25 A kind of preparation method of chitosan multi-porous styptic sponge

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510990788.XA CN105536029B (en) 2015-12-25 2015-12-25 A kind of preparation method of chitosan multi-porous styptic sponge

Publications (2)

Publication Number Publication Date
CN105536029A CN105536029A (en) 2016-05-04
CN105536029B true CN105536029B (en) 2018-07-13

Family

ID=55815900

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510990788.XA Active CN105536029B (en) 2015-12-25 2015-12-25 A kind of preparation method of chitosan multi-porous styptic sponge

Country Status (1)

Country Link
CN (1) CN105536029B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106178086A (en) * 2016-08-19 2016-12-07 蓝广芊 A kind of preparation method of the porous sthptic sponge containing Argent grain
CN106620824B (en) * 2016-12-30 2019-07-02 广东海洋大学 A kind of preparation method of high-efficiency antimicrobial compound hemostatic sponge
RU2681184C1 (en) * 2018-02-26 2019-03-04 Общество с ограниченной ответственностью "Специальная и медицинская техника" (ООО "Спецмедтехника") Hemostatic sponge
CN109620999A (en) * 2019-01-12 2019-04-16 王若梅 A kind of preparation method of compound hemostatic medical tissue glue
CN109731127B (en) * 2019-02-27 2020-06-16 西南交通大学 Porous hemostatic sponge and preparation method thereof
CN111001034A (en) * 2020-02-08 2020-04-14 欧嘉杰 Degradable polyvinyl alcohol-based composite hemostatic material
CN112646228B (en) * 2020-12-21 2023-01-13 嘉兴学院 Tannin crosslinked chitosan/gelatin imbibing hemostatic antibacterial sponge and preparation method thereof
CN113577372A (en) * 2021-08-13 2021-11-02 广州市周平喜医疗科技有限公司 Medical hemostatic composite material and preparation method thereof
CN115068685A (en) * 2022-07-01 2022-09-20 张培华 Platelet-rich fibrin composite membrane and preparation method and application thereof
CN115671373B (en) * 2022-10-17 2024-02-27 苏州昊微新材料科技有限公司 GelMA-DA/quaternized chitosan/glycerol composite hemostatic sponge material and preparation method thereof
CN115737891A (en) * 2022-11-23 2023-03-07 西南大学 Peach gum-based hemostatic porous sponge and application
CN116212103A (en) * 2023-05-11 2023-06-06 北京康宇建医疗器械有限公司 Chitosan gel dressing for promoting healing as well as preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1485097A (en) * 2003-08-22 2004-03-31 北京益而康生物工程开发中心 Prepration process for biologic hemostatic sponge material
CN1775302A (en) * 2005-11-23 2006-05-24 广东海洋大学 Chitose-gelatine sponge wound dressing preparing method
CN102416194A (en) * 2011-11-11 2012-04-18 汤小国 Novel chitosan hemostatic sponge and preparation method thereof
CN104874013A (en) * 2015-05-22 2015-09-02 苏州市贝克生物科技有限公司 Preparation method of medical hemostatic sponge material

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1485097A (en) * 2003-08-22 2004-03-31 北京益而康生物工程开发中心 Prepration process for biologic hemostatic sponge material
CN1775302A (en) * 2005-11-23 2006-05-24 广东海洋大学 Chitose-gelatine sponge wound dressing preparing method
CN102416194A (en) * 2011-11-11 2012-04-18 汤小国 Novel chitosan hemostatic sponge and preparation method thereof
CN104874013A (en) * 2015-05-22 2015-09-02 苏州市贝克生物科技有限公司 Preparation method of medical hemostatic sponge material

Also Published As

Publication number Publication date
CN105536029A (en) 2016-05-04

Similar Documents

Publication Publication Date Title
CN105536029B (en) A kind of preparation method of chitosan multi-porous styptic sponge
CN104548187B (en) A kind of modification alginic acid and gelatin cross-blend sponge and preparation method and application
Kang et al. Development and assessment of hemostasis chitosan dressings
CN106421880B (en) A kind of Sepia polysaccharide/chitosan styptic sponge and its preparation method and application
CN100348272C (en) Method for preparing astringent sponge of soluble cellulose
CN104474575B (en) Shitosan hemostatic material that covalent cross-linking is formed and preparation method thereof
Huang et al. Preparation and evaluation of squid ink polysaccharide-chitosan as a wound-healing sponge
CN104030278B (en) A kind of preparation method of crosslinked graphene sponge and the application in trauma hemostasis thereof
US11529305B2 (en) Scrub sponge and preparation method therefor
Chen et al. Fabrication of porous starch microspheres by electrostatic spray and supercritical CO2 and its hemostatic performance
Chen et al. A quaternized chitosan and carboxylated cellulose nanofiber-based sponge with a microchannel structure for rapid hemostasis and wound healing
CN108853570A (en) A kind of styptic sponge and preparation method thereof
CN103418020B (en) Devilstongue gulcomannan hemostatic sponge and preparation method thereof
CN107261200A (en) A kind of chitosan nano lithium diatomaceous earth plural gel wound dressing and preparation method thereof
Wang et al. Fabrication of microspheres containing coagulation factors by reverse microemulsion method for rapid hemostasis and wound healing
CN103877606A (en) Absorbable bleeding-stopping compound sponge and preparation method thereof
CN103012859B (en) Chitosan and propylene glycol alginate blending material as well as preparation method and application thereof
CN104069535B (en) A kind of Preparation method and use of biological activity composite membrane bleeding-stopping dressing
CN106902383A (en) A kind of nanogel hemostatic material of modified glucan modification and its preparation and application
CN106178086A (en) A kind of preparation method of the porous sthptic sponge containing Argent grain
ES2741015T3 (en) Dry pad comprising thrombin and pectin
CN105944135A (en) Composite sponge and preparation method thereof
CN104307031B (en) A kind of Preparation method and use of external preparation for skin repair materials
CN105617448A (en) Fibrous protein compound hemostatic material and preparation method thereof
Zhang et al. Recent advances of chitosan as a hemostatic material: Hemostatic mechanism, material design and prospective application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20181026

Address after: 215505 2 Jianye Road, Changshou City, Jiangsu

Patentee after: Suzhou and its beauty biological materials Co., Ltd.

Address before: 400716 College of textile and garment, Southwestern University, No. 216 Tiansheng Road, Beibei, Chongqing

Patentee before: Lan Guangqian

TR01 Transfer of patent right